Pear
Boston, United States · Founded 2013 · $234.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Total Funding
- $234.0M
- Last Round
- $100.0M Series DDec 2021
- Rounds
- 4
About
Pioneer in FDA-cleared prescription digital therapeutics for substance use disorder and mental health.
Summary
Pear is a Biotech company based in Boston, United States, founded in 2013. It has raised $234.0M in total across 4 rounds, most recently a $100.0M Series D round in Dec 2021. Investors include Arboretum Ventures, 5AM Ventures and SoftBank.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png)
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...